A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd T Lymphoblastic Lymphoma (T-LLy)

Submitted by centretek on Sat, 10/15/2022 - 10:29

Source URL

https://www.inova.org/clinical-trials/phase-3-randomized-trial-investigating-bortezomib-nsc681239-ind58443-modified

Description

General Information Age Group Pediatrics/Children Status Active Protocol Number AALL1231 Offered At Inova Children's Hospital 3300 Gallows Road Falls Church, VA 22042 Contact Information Contact Name Keary Jane't Contact Phone 703-776-3456 Contact Email Send Email

Clinical Trials Category

Cancer

Clinical Trials Sub categories

Leukemia

Crawled Content Type

Clinical Trials

A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd T­ Lymphoblastic Lymphoma (T-LLy)

A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd T Lymphoblastic Lymphoma (T-LLy)